RESEARCH NEWS
FDA Approves First Drug for Group 3 PH
The FDA recently approved Tyvaso (treprostinil) Inhalation Solution to improve exercise ability for people who have PH associated with interstitial lung disease. Manufactured by United Therapeutics, Tyvaso is the first FDA-approved treatment for Group 3 PH.
PHA Names Research Award Recipient
Vineet Agrawal, M.D., Ph.D., is the 2020 recipient of the Pulmonary Hypertension Association’s Aldrighetti Research Award for Young Investigators. Dr. Agrawal is a physician-scientist and instructor of medicine at Vanderbilt University Medical Center.
How Does Body Weight Affect PAH?
A new article based Pulmonary Hypertension Association Registry (PHAR) data suggests body weight plays a complex, important role in pulmonary arterial hypertension (PAH). The article, which recently was published in the Annals of the American Thoracic Society, investigated the effects of patient weight on day-to-day activities.
Find Out the Latest in PH Research
Learn about the latest discoveries in pulmonary hypertension (PH) research. Join the Pulmonary Hypertension Association (PHA) at 3 p.m. EDT, Oct. 9 for “Advancements in PH Research.” Dr. Todd Bull will provide an update on the scientific discoveries and research that could lead to the next generation of PH therapies.
How to Maximize Your Support for PH Research and Awareness
Does your employer have a matching gift program? If so, you can double your contribution to the Pulmonary Hypertension Association (PHA). Depending on the employer, you might be eligible to provide twice the support for the pulmonary hypertension (PH) community, whether you’re an employee, spouse of an employee or retiree.
Discover Patient and Researcher Perspectives on PH Drug Development
Would you like to learn more about the process of developing new drugs to treat pulmonary hypertension (PH)? Check out the latest issue of the Pulmonary Hypertension Association’s (PHA’s) official journal, Advances in Pulmonary Hypertension, now available online.
Advances in Pulmonary Hypertension
Read the latest issue of Advances in Pulmonary Hypertension, PHA’s quarterly medical journal.